AMYLIN - European Union Trademark Information

The trademark registration for AMYLIN was filed on March 4, 2011, and it was registered on August 15, 2011 under EUTM trademark no. 009786724.

The trademark is owned by ASTRAZENECA PHARMACEUTICALS LP and represented by ELZABURU, S.L.P. (EUIPO registered representative, ID no. 11849) as a holder of a trademark.

There were no oppositions raised during the publication period. The 90 day opposition period for this mark started on May 6, 2011.

Trademark registration is in force until March 4, 2021.

TRADEMARK INFORMATION
Trademark Name AMYLIN Trademark No. 009786724
Type Figurative Status Registered
Filling Date March 4, 2011 Registration Date August 15, 2011
NICE Classes 5 Basis EUTM
Reference 327256/JPC/sjc Status Date August 18, 2011
Owner Information
Owner ASTRAZENECA PHARMACEUTICALS LP
Owner ID 904461
Legal Status Legal entity
Country US
Address ASTRAZENECA PHARMACEUTICALS LP
1800 Concord Pike
Wilmington DE 19850
UNITED STATES
Representative Information
Representative ELZABURU, S.L.P.
Representative ID 11849
Legal Status Legal person
Country ES
Address ELZABURU, S.L.P.
Miguel Angel, 21
E-28010 Madrid
SPAIN
NICE CLASS Descriptions
Class Class Description
5
Pharmaceutical, Veterinary Products, Dietetic

Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, endocrine conditions and disorders, glucoregulatory disorders, diabetes, diabetic complications, hormonal diseases and disorders, overweight and obesity, cardiovascular diseases and disorders, gastrointestinal disorders, immunological disorders, inflammation and inflammatory diseases.

Disclaimer: The information provided on this page is considered public information by the European Union Intellectual Property Office and is provided for informational purposes only. It should not be construed as legal advice on any subject matter.